Company
Headquarters: Chengdu, China
CN¥2.00 Billion
CNY as of July 1, 2024
US$274.6 Million
| Company | Market Cap (USD) |
|---|---|
| Lilly | $808.65 B |
| Novo Nordisk | $622.07 B |
| UnitedHealth Group | $450.89 B |
| Johnson & Johnson | $350.63 B |
| Merck | $318.75 B |
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co., Ltd. distributes generic drugs and Chinese medicines in China. The company offers medications in the areas of respiratory, anti-inflammatory, five senses, skin and external, digestive, hepatobiliary system, rehabilitation and tranquility, women, pediatrics, cardiovascular and neurological, endocrine system, rheumatoid bone injury, and others. It also provides special compound preparations, biological products, Chinese herbal medicines, and non-medicine products. The company was founded in 2007 and is based in Chengdu, China.
Top 1-year algo backtest: +265.99%
$10,000 in October 2023 would now be $36,599 by following this algorithm daily at market close.
Use AI to boost your investing & swing trading, now!
Try Disfold DeepFinance FREE
Sichuan Hezong Medicine Easy-to-buy Pharmaceutical Co. Ltd has the following listings and related stock indices.
Stock: SZSE: 300937 wb_incandescent